vs
Side-by-side financial comparison of PLUS THERAPEUTICS, INC. (PSTV) and Expion360 Inc. (XPON). Click either name above to swap in a different company.
Expion360 Inc. is the larger business by last-quarter revenue ($2.2M vs $1.4M, roughly 1.6× PLUS THERAPEUTICS, INC.). Expion360 Inc. runs the higher net margin — -199.9% vs -417.9%, a 218.0% gap on every dollar of revenue. On growth, Expion360 Inc. posted the faster year-over-year revenue change (11.8% vs -3.2%). Over the past eight quarters, Expion360 Inc.'s revenue compounded faster (51.1% CAGR vs -9.7%).
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
Expion360 Inc. is a provider of high-performance lithium iron phosphate (LFP) battery solutions and supporting energy storage products. Its core customer segments cover recreational vehicle owners, marine users, off-grid lifestyle enthusiasts and residential users across the U.S. market, delivering safe, durable and low-carbon energy storage options.
PSTV vs XPON — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4M | $2.2M |
| Net Profit | $-5.7M | $-4.4M |
| Gross Margin | — | -14.8% |
| Operating Margin | -420.0% | -234.4% |
| Net Margin | -417.9% | -199.9% |
| Revenue YoY | -3.2% | 11.8% |
| Net Profit YoY | -46.4% | -1663.2% |
| EPS (diluted) | $0.95 | $-0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4M | $2.2M | ||
| Q3 25 | $1.4M | $2.4M | ||
| Q2 25 | $1.4M | $3.0M | ||
| Q1 25 | $1.1M | $2.0M | ||
| Q4 24 | $1.4M | $2.0M | ||
| Q3 24 | $1.5M | $1.4M | ||
| Q2 24 | $1.3M | $1.3M | ||
| Q1 24 | $1.7M | $971.9K |
| Q4 25 | $-5.7M | $-4.4M | ||
| Q3 25 | $-4.4M | $722.8K | ||
| Q2 25 | $5.2M | $-1.4M | ||
| Q1 25 | $-17.4M | $-1.2M | ||
| Q4 24 | $-3.9M | $-251.6K | ||
| Q3 24 | $-2.9M | $-8.8M | ||
| Q2 24 | $-2.9M | $-2.2M | ||
| Q1 24 | $-3.3M | $-2.2M |
| Q4 25 | — | -14.8% | ||
| Q3 25 | — | 22.7% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | — | 24.5% | ||
| Q4 24 | — | 22.1% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 25.5% | ||
| Q1 24 | — | 22.9% |
| Q4 25 | -420.0% | -234.4% | ||
| Q3 25 | -320.8% | -125.4% | ||
| Q2 25 | -110.6% | -45.2% | ||
| Q1 25 | -333.9% | -56.0% | ||
| Q4 24 | -276.2% | -59.5% | ||
| Q3 24 | -260.9% | -138.7% | ||
| Q2 24 | -289.1% | -131.4% | ||
| Q1 24 | -196.7% | -202.4% |
| Q4 25 | -417.9% | -199.9% | ||
| Q3 25 | -316.6% | 30.2% | ||
| Q2 25 | 370.6% | -45.8% | ||
| Q1 25 | -1643.2% | -56.2% | ||
| Q4 24 | -276.4% | -12.7% | ||
| Q3 24 | -197.4% | -634.4% | ||
| Q2 24 | -229.9% | -173.7% | ||
| Q1 24 | -194.5% | -225.6% |
| Q4 25 | $0.95 | $-0.45 | ||
| Q3 25 | $-0.04 | $0.10 | ||
| Q2 25 | $-0.01 | $-0.41 | ||
| Q1 25 | $-1.19 | $-0.37 | ||
| Q4 24 | $-0.51 | $65.02 | ||
| Q3 24 | $-0.37 | $-24.55 | ||
| Q2 24 | $-0.71 | $-30.20 | ||
| Q1 24 | $-0.75 | $-31.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.6M | $3.0M |
| Total DebtLower is stronger | — | $197.2K |
| Stockholders' EquityBook value | $4.0M | $6.5M |
| Total Assets | $16.3M | $8.1M |
| Debt / EquityLower = less leverage | — | 0.03× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.6M | $3.0M | ||
| Q3 25 | $16.6M | $4.3M | ||
| Q2 25 | $6.9M | $684.9K | ||
| Q1 25 | $9.9M | $1.1M | ||
| Q4 24 | $3.6M | $547.6K | ||
| Q3 24 | $4.8M | $3.3M | ||
| Q2 24 | $8.4M | $902.3K | ||
| Q1 24 | $3.2M | $2.3M |
| Q4 25 | — | $197.2K | ||
| Q3 25 | — | $205.6K | ||
| Q2 25 | — | $213.6K | ||
| Q1 25 | — | $221.8K | ||
| Q4 24 | — | $230.2K | ||
| Q3 24 | — | $239.9K | ||
| Q2 24 | — | $247.7K | ||
| Q1 24 | — | $255.4K |
| Q4 25 | $4.0M | $6.5M | ||
| Q3 25 | $5.1M | $9.0M | ||
| Q2 25 | $3.0M | $2.1M | ||
| Q1 25 | $-23.6M | $3.2M | ||
| Q4 24 | $-8.9M | $2.5M | ||
| Q3 24 | $-5.2M | $2.5M | ||
| Q2 24 | $-7.6M | $2.5M | ||
| Q1 24 | $-4.8M | $3.7M |
| Q4 25 | $16.3M | $8.1M | ||
| Q3 25 | $18.7M | $10.7M | ||
| Q2 25 | $10.3M | $8.6M | ||
| Q1 25 | $12.1M | $9.2M | ||
| Q4 24 | $6.6M | $9.1M | ||
| Q3 24 | $7.0M | $10.1M | ||
| Q2 24 | $11.2M | $8.8M | ||
| Q1 24 | $5.6M | $10.0M |
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.10× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.09× | ||
| Q3 24 | — | 0.09× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.3M | $-2.4M |
| Free Cash FlowOCF − Capex | $-6.3M | — |
| FCF MarginFCF / Revenue | -459.9% | — |
| Capex IntensityCapex / Revenue | 2.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-20.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.3M | $-2.4M | ||
| Q3 25 | $-2.5M | $-2.1M | ||
| Q2 25 | $-5.8M | $-401.0K | ||
| Q1 25 | $-6.2M | $-1.2M | ||
| Q4 24 | $-1.2M | $-2.9M | ||
| Q3 24 | $-3.7M | $-3.2M | ||
| Q2 24 | $-1.1M | $-1.7M | ||
| Q1 24 | $-4.5M | $-1.7M |
| Q4 25 | $-6.3M | — | ||
| Q3 25 | $-2.6M | — | ||
| Q2 25 | $-5.8M | — | ||
| Q1 25 | $-6.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.7M | — | ||
| Q2 24 | $-1.2M | — | ||
| Q1 24 | $-4.6M | $-1.7M |
| Q4 25 | -459.9% | — | ||
| Q3 25 | -184.3% | — | ||
| Q2 25 | -417.6% | — | ||
| Q1 25 | -583.1% | — | ||
| Q4 24 | -86.5% | — | ||
| Q3 24 | -253.7% | — | ||
| Q2 24 | -96.2% | — | ||
| Q1 24 | -271.5% | -173.1% |
| Q4 25 | 2.2% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 6.3% | — | ||
| Q1 24 | 2.4% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | -2.90× | ||
| Q2 25 | -1.13× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
